• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19大流行两年期间ST段抬高型心肌梗死患者的概况及全因院内死亡动态

The Profile and All-Cause In-Hospital Mortality Dynamics of St-Segment Elevation Myocardial Infarction Patients during the Two Years of the COVID-19 Pandemic.

作者信息

Popa-Fotea Nicoleta-Monica, Grigore Iulia-Adelina, Calmac Lucian, Mihai Cosmin, Bataila Vlad, Ploscaru Vlad, Dragoescu Bogdan, Moldovan Horatiu, Busnatu Stefan-Sebastian, Panaitescu Eugenia, Iliuță Luminita, Scafa-Udriște Alexandru

机构信息

Department of Cardio-Thoracic Pathology, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.

Department of Cardiology, Emergency Clinical Hospital, 014461 Bucharest, Romania.

出版信息

J Clin Med. 2023 Feb 12;12(4):1467. doi: 10.3390/jcm12041467.

DOI:10.3390/jcm12041467
PMID:36836002
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9960631/
Abstract

During the coronavirus pandemic 2019 (COVID-19), some studies showed differences in the profile of subjects presenting with acute coronary syndromes as well as in overall mortality due to the delay of presentation and other complications. The purpose of this study was to compare the profile and outcomes, with emphasis on all-cause in-hospital mortality, of ST-elevation myocardial infarction (STEMI) subjects presenting to the emergency department during the pandemic period compared with a control group from the previous year, 2019. The study enrolled 2011 STEMI cases, which were divided into two groups-pre-pandemic (2019-2020) and pandemic period (2020-2022). Hospital admissions for a STEMI diagnosis sharply decreased during the COVID-19 period by 30.26% during the first year and 25.4% in the second year. This trend was paralleled by a significant increase in all-cause in-hospital mortality: 11.5% in the pandemic period versus 8.1% in the previous year. There was a significant association between SARS-CoV-2 positivity and all-cause in-hospital mortality, but no correlation was found between COVID-19 diagnosis and the type of revascularization. However, the profile of subjects presenting with STEMI did not change over time during the pandemic; their demographic and comorbid characteristics remained similar.

摘要

在2019年冠状病毒大流行(COVID-19)期间,一些研究表明,因就诊延迟和其他并发症,出现急性冠状动脉综合征的患者情况以及总体死亡率存在差异。本研究的目的是比较大流行期间到急诊科就诊的ST段抬高型心肌梗死(STEMI)患者与2019年上一年的对照组在特征和结局方面的差异,重点关注全因住院死亡率。该研究纳入了2011例STEMI病例,分为两组——大流行前(2019 - 2020年)和大流行期间(2020 - 2022年)。在COVID - 19期间,STEMI诊断的住院人数在第一年急剧下降了30.26%,在第二年下降了25.4%。这一趋势伴随着全因住院死亡率的显著上升:大流行期间为11.5%,而上一年为8.1%。SARS-CoV-2阳性与全因住院死亡率之间存在显著关联,但未发现COVID-19诊断与血运重建类型之间存在相关性。然而,在大流行期间,出现STEMI的患者情况并未随时间变化;他们的人口统计学和合并症特征保持相似。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97e0/9960631/ef973094ae54/jcm-12-01467-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97e0/9960631/ef973094ae54/jcm-12-01467-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97e0/9960631/ef973094ae54/jcm-12-01467-g001.jpg

相似文献

1
The Profile and All-Cause In-Hospital Mortality Dynamics of St-Segment Elevation Myocardial Infarction Patients during the Two Years of the COVID-19 Pandemic.COVID-19大流行两年期间ST段抬高型心肌梗死患者的概况及全因院内死亡动态
J Clin Med. 2023 Feb 12;12(4):1467. doi: 10.3390/jcm12041467.
2
Impact of the COVID-19 Pandemic on Patient Delay and Clinical Outcomes for Patients With Acute Myocardial Infarction.COVID-19 大流行对急性心肌梗死患者的就诊延迟和临床结局的影响。
J Korean Med Sci. 2022 May 30;37(21):e167. doi: 10.3346/jkms.2022.37.e167.
3
Impact of the SARS-CoV-2 pandemic on acute coronary syndrome patients admitted to an urban academic hospital in Soweto, South Africa.南非索韦托市一所城市学术医院收治的急性冠状动脉综合征患者中 SARS-CoV-2 大流行的影响。
Pan Afr Med J. 2024 Apr 3;47:160. doi: 10.11604/pamj.2024.47.160.37066. eCollection 2024.
4
Ongoing COVID-19 Pandemic Effects on Admissions and In-Hospital Outcomes in Patients With ST-Elevation Myocardial Infarction (STEMI): An Albanian Observational Study.2019冠状病毒病大流行对ST段抬高型心肌梗死(STEMI)患者入院情况及住院结局的持续影响:一项阿尔巴尼亚的观察性研究。
Cureus. 2022 Jul 13;14(7):e26813. doi: 10.7759/cureus.26813. eCollection 2022 Jul.
5
ST-Segment-Elevation Myocardial Infarction During COVID-19 Pandemic: Insights From a Regional Public Service Healthcare Hub.COVID-19 大流行期间的 ST 段抬高型心肌梗死:区域性公共服务医疗中心的观察结果。
Circ Cardiovasc Interv. 2020 Aug;13(8):e009413. doi: 10.1161/CIRCINTERVENTIONS.120.009413. Epub 2020 Aug 14.
6
Initial Single-Center ST-Segment Elevation Myocardial Infarction Experience in New York Before and During the COVID-19 Pandemic.在 COVID-19 大流行前后纽约的初始单中心 ST 段抬高型心肌梗死经验。
Cardiovasc Revasc Med. 2022 Jan;34:80-85. doi: 10.1016/j.carrev.2021.01.026. Epub 2021 Jan 26.
7
Impact of SARS-CoV-2 pandemic on ST-elevation myocardial infarction admissions and outcomes in a Portuguese primary percutaneous coronary intervention center: Preliminary Data.新型冠状病毒肺炎大流行对葡萄牙经皮冠状动脉介入治疗中心 ST 段抬高型心肌梗死患者入院和结局的影响:初步数据。
Rev Port Cardiol (Engl Ed). 2021 Jul;40(7):465-471. doi: 10.1016/j.repce.2021.07.014.
8
Impact of COVID-19 outbreak on patients with ST-segment elevation myocardial ınfarction (STEMI) in Turkey: results from TURSER study (TURKISH St-segment elevation myocardial ınfarction registry).新型冠状病毒肺炎疫情对土耳其 ST 段抬高型心肌梗死(STEMI)患者的影响:TURSER 研究(土耳其 ST 段抬高型心肌梗死注册研究)结果。
J Thromb Thrombolysis. 2022 Feb;53(2):321-334. doi: 10.1007/s11239-021-02487-3. Epub 2021 May 29.
9
Increased mortality and worse cardiac outcome of acute myocardial infarction during the early COVID-19 pandemic.新冠肺炎大流行早期急性心肌梗死患者的死亡率增加和心脏预后更差。
ESC Heart Fail. 2021 Feb;8(1):333-343. doi: 10.1002/ehf2.13075. Epub 2020 Dec 6.
10
Effects of the COVID-19 pandemic on acute coronary syndromes in Germany during the first wave: the COVID-19 collateral damage study.新冠疫情大流行对德国第一波疫情期间急性冠状动脉综合征的影响:COVID-19 附带损害研究。
Clin Res Cardiol. 2023 Apr;112(4):539-549. doi: 10.1007/s00392-022-02082-3. Epub 2022 Aug 17.

引用本文的文献

1
Ten-year review of ST-Segment Elevation Myocardial Infarction (STEMI) in Tanzania: a single center retrospective review.坦桑尼亚ST段抬高型心肌梗死(STEMI)的十年回顾:一项单中心回顾性研究
Pan Afr Med J. 2024 Nov 18;49:82. doi: 10.11604/pamj.2024.49.82.45351. eCollection 2024.
2
Acute Myocardial Infarction in the Era of COVID-19: A Challenge in a Challenge.2019冠状病毒病时代的急性心肌梗死:挑战中的挑战
J Clin Med. 2023 Sep 5;12(18):5779. doi: 10.3390/jcm12185779.
3
Challenges in Caring for People with Cardiovascular Disease through and beyond the COVID-19 Pandemic: The Advantages of Universal Access to Home Telemonitoring.

本文引用的文献

1
Myocardial Ischemia in Patients with COVID-19 Infection: Between Pathophysiological Mechanisms and Electrocardiographic Findings.新型冠状病毒肺炎感染患者的心肌缺血:病理生理机制与心电图表现之间的关系
Life (Basel). 2022 Jul 8;12(7):1015. doi: 10.3390/life12071015.
2
Risk factors for developing COVID-19: a population-based longitudinal study (COVIDENCE UK).新冠病毒(COVID-19)发病风险因素:基于人群的纵向研究(COVIDENCE UK)。
Thorax. 2022 Sep;77(9):900-912. doi: 10.1136/thoraxjnl-2021-217487. Epub 2021 Nov 30.
3
Brescia-COVID Respiratory Severity Scale (BRCSS) and Quick SOFA (qSOFA) score are most useful in showing severity in COVID-19 patients.
在新冠疫情期间及之后照顾心血管疾病患者面临的挑战:普遍使用家庭远程监测的优势
Healthcare (Basel). 2023 Jun 12;11(12):1727. doi: 10.3390/healthcare11121727.
4
Telemedicine for Optimizing Secondary Prevention in Coronary Artery Bypass Grafting Patients during COVID-19 Pandemic.在新冠疫情期间,利用远程医疗优化冠状动脉搭桥手术患者的二级预防
Healthcare (Basel). 2023 May 29;11(11):1590. doi: 10.3390/healthcare11111590.
布雷西亚-COVID 呼吸严重程度评分(BRCSS)和快速序贯器官衰竭评估(qSOFA)评分最能显示 COVID-19 患者的严重程度。
Sci Rep. 2021 Nov 8;11(1):21807. doi: 10.1038/s41598-021-01181-x.
4
Clinical presentation, disease course, and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease: a cohort study across 18 countries.合并或未合并基础心脏病的住院COVID-19患者的临床表现、疾病进程及预后:一项涵盖18个国家的队列研究
Eur Heart J. 2022 Mar 14;43(11):1104-1120. doi: 10.1093/eurheartj/ehab656.
5
Association Between COVID-19 Diagnosis and In-Hospital Mortality in Patients Hospitalized With ST-Segment Elevation Myocardial Infarction.COVID-19 诊断与因 ST 段抬高型心肌梗死住院患者院内死亡率的相关性。
JAMA. 2021 Nov 16;326(19):1940-1952. doi: 10.1001/jama.2021.18890.
6
COVID-19 pandemic, mechanical reperfusion and 30-day mortality in ST elevation myocardial infarction.COVID-19 大流行、机械再灌注与 ST 段抬高型心肌梗死 30 天死亡率。
Heart. 2022 Mar;108(6):458-466. doi: 10.1136/heartjnl-2021-319750. Epub 2021 Oct 28.
7
International Prospective Registry of Acute Coronary Syndromes in Patients With COVID-19.国际 COVID-19 合并急性冠状动脉综合征患者前瞻性登记研究。
J Am Coll Cardiol. 2021 May 25;77(20):2466-2476. doi: 10.1016/j.jacc.2021.03.309.
8
Outcomes of COVID-19-positive acute coronary syndrome patients: A multisource electronic healthcare records study from England.COVID-19 阳性急性冠状动脉综合征患者的结局:来自英国的多源电子医疗记录研究。
J Intern Med. 2021 Jul;290(1):88-100. doi: 10.1111/joim.13246. Epub 2021 Mar 13.
9
Effect of the COVID-19 pandemic on mortality of patients with STEMI: a systematic review and meta-analysis.2019年冠状病毒病大流行对ST段抬高型心肌梗死患者死亡率的影响:一项系统评价和荟萃分析。
Heart. 2020 Dec 17. doi: 10.1136/heartjnl-2020-318360.
10
Comorbidity and its Impact on Patients with COVID-19.合并症及其对COVID-19患者的影响。
SN Compr Clin Med. 2020;2(8):1069-1076. doi: 10.1007/s42399-020-00363-4. Epub 2020 Jun 25.